BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37266656)

  • 21. Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study.
    Hida T; Hata A; Lu J; Valtchinov VI; Hino T; Nishino M; Honda H; Tomiyama N; Christiani DC; Hatabu H
    Cancer Imaging; 2021 Jan; 21(1):14. PubMed ID: 33468255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Interstitial Lung Abnormality on Concurrent Chemoradiotherapy-treated Stage III Non-small Cell Lung Cancer Patients.
    Jeong WG; Kim YH; Ahn SJ; Jeong JU; Lee BC; Cho IJ; Kim YH
    Anticancer Res; 2023 Apr; 43(4):1797-1807. PubMed ID: 36974810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
    Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
    Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of CT quantification in progressive fibrosing interstitial lung disease: a deep learning approach.
    Koh SY; Lee JH; Park H; Goo JM
    Eur Radiol; 2023 Dec; ():. PubMed ID: 38085286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study.
    Walsh SLF; Calandriello L; Silva M; Sverzellati N
    Lancet Respir Med; 2018 Nov; 6(11):837-845. PubMed ID: 30232049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort.
    Lee JE; Chae KJ; Suh YJ; Jeong WG; Lee T; Kim YH; Jin GY; Jeong YJ
    Radiology; 2023 Feb; 306(2):e221172. PubMed ID: 36219115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease.
    Sekihara K; Aokage K; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Hishida T; Yoshida J; Hisakane K; Goto K; Tsuboi M
    Interact Cardiovasc Thorac Surg; 2018 Apr; 26(4):638-643. PubMed ID: 29272403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative Assessment of Airway Changes in Fibrotic Interstitial Lung Abnormality Patients by Chest CT According to Cumulative Cigarette Smoking.
    Li YZ; Jin GY; Chae KJ; Han YM
    Tomography; 2022 Apr; 8(2):1024-1032. PubMed ID: 35448716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.
    Maeda H; Kanzaki M; Sakamoto K; Isaka T; Oyama K; Murasugi M; Onuki T
    Surg Today; 2017 Sep; 47(9):1072-1079. PubMed ID: 28247107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchial epithelial gene expression and interstitial lung abnormalities.
    Menon AA; Lee M; Ke X; Putman RK; Hino T; Rose JA; Duan F; Ash SY; Cho MH; O'Connor GT; Dupuis J; Hatabu H; Lenburg ME; Billatos ES; Hunninghake GM;
    Respir Res; 2023 Oct; 24(1):245. PubMed ID: 37817229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
    Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
    AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
    [No Abstract]   [Full Text] [Related]  

  • 33. Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP).
    Hino T; Lee KS; Yoo H; Han J; Franks TJ; Hatabu H
    Eur J Radiol Open; 2021; 8():100336. PubMed ID: 33796637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial Lung Abnormalities at CT in the Korean National Lung Cancer Screening Program: Prevalence and Deep Learning-based Texture Analysis.
    Chae KJ; Lim S; Seo JB; Hwang HJ; Choi H; Lynch D; Jin GY
    Radiology; 2023 May; 307(4):e222828. PubMed ID: 37097142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Baseline Interstitial Lung Abnormalities on Pneumonitis Risk in Patients Receiving Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer.
    Petranovic M; McDermott S; Mercaldo S; Little BP; Graur A; Huang K; Fintelmann FJ; Digumarthy SR; Gainor JF
    Clin Lung Cancer; 2023 Dec; 24(8):682-688.e5. PubMed ID: 37758549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.
    Nishino M; Cardarella S; Dahlberg SE; Araki T; Lydon C; Jackman DM; Rabin MS; Hatabu H; Johnson BE
    Eur J Radiol; 2015 May; 84(5):998-1004. PubMed ID: 25726730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.
    Jin GY; Lynch D; Chawla A; Garg K; Tammemagi MC; Sahin H; Misumi S; Kwon KS
    Radiology; 2013 Aug; 268(2):563-71. PubMed ID: 23513242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implication of interstitial lung abnormality in elderly patients with early-stage non-small cell lung cancer.
    Cho SW; Jeong WG; Lee JE; Oh IJ; Song SY; Park HM; Lee HJ; Kim YH
    Thorac Cancer; 2022 Apr; 13(7):977-985. PubMed ID: 35150070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glasgow Prognostic Score predicts chemotherapy-triggered acute exacerbation-interstitial lung disease in patients with non-small cell lung cancer.
    Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
    Thorac Cancer; 2021 Mar; 12(5):667-675. PubMed ID: 33480111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease.
    Shao C; Zhi X; Mao S; Wu L; Yu J; Yang S; Wang W; Jia K; Luo L; Liu X; Jiang T; Zhou F; Chen B; Wang L; Gao G; Shi J; Chen X; Wu F; Ren S
    Thorac Cancer; 2024 Apr; 15(10):778-787. PubMed ID: 38400790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.